Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
about
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundMiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1α and VEGFA: Implications for psoriasis treatment.Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions.Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment.Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells.Clinical and Capillaroscopic Modifications of the Psoriatic Plaque during Therapy: Observations with Oral Acitretin.VEGF involvement in psoriasis.The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis.Study of in vitro capillary-like structures in psoriatic skin substitutes.Videocapillaroscopic findings in the microcirculation of the psoriatic plaque during etanercept therapy.Combined clinical, capillaroscopic and ultrasound evaluation during treatment of plaque psoriasis with oral cyclosporine.German S3-guidelines on the treatment of psoriasis vulgaris (short version).Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis?T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis
P2860
Q26765175-9BD7E985-FDEE-42FE-8663-BA657E95C116Q33554379-5FEE2636-D0F5-44BE-9EB5-B81725ECD313Q34428875-9176FECA-D52C-47A3-99C5-8098B32F7B39Q34504431-F5C01F8B-47E5-494D-A55F-AAC2B1029945Q37022066-3C0E3B58-7B25-4BC7-B101-218BECD0A57EQ37224890-089C2694-E391-4FF6-B6D2-9FDE89CA18A8Q38648336-A3180708-1297-4A23-9321-8D8BECD5F84CQ42008371-2BF3D7C9-17A3-47D9-91FC-15FC0AEDA071Q42039509-82894AAA-CEE4-4BF5-BC29-42E250063F49Q45777075-0070E886-EEF5-49D5-AC68-7609D0730CC7Q46064797-B86EB34D-DBC3-491D-A79A-B25964769C16Q48480123-4AED83B7-6908-47C6-A36F-BDFC12C60715Q51122128-E746BF87-531D-4A83-A450-62112925DB14Q51496285-4B6EA703-8ACC-45B3-AC18-2E5D8540C3DAQ52888818-A514EAA3-5FD2-444B-BC2A-4E77DC1B94AEQ57272045-60D90BDC-0E4D-4EC4-B133-166517A72C33
P2860
Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Angiogenesis in psoriatic skin ...... mmunohistochemical evaluation.
@en
Angiogenesis in psoriatic skin ...... mmunohistochemical evaluation.
@nl
type
label
Angiogenesis in psoriatic skin ...... mmunohistochemical evaluation.
@en
Angiogenesis in psoriatic skin ...... mmunohistochemical evaluation.
@nl
prefLabel
Angiogenesis in psoriatic skin ...... mmunohistochemical evaluation.
@en
Angiogenesis in psoriatic skin ...... mmunohistochemical evaluation.
@nl
P2093
P2860
P1476
Angiogenesis in psoriatic skin ...... mmunohistochemical evaluation.
@en
P2093
A Campanati
A Giuliano
A Offidani
D Stramazzotti
G Ganzetti
K Giuliodori
P2860
P304
P356
10.1177/039463200902200214
P577
2009-04-01T00:00:00Z